Results of a Comparative Study with Adalat: Phonomechano-Cardiograms in Normal Persons and Patients with Coronary Heart Disease

Esper, Ricardo J.; Machado, Rogelio A.; Nordaby, Roberto A.; Bidoggia, H

doi:10.1007/978-3-642-66241-6_24

2nd International Adalat® Symposium 1975

DOI: 10.1007/978-3-642-66241-6_24

|View full text |Cite

Results of a Comparative Study with Adalat: Phonomechano-Cardiograms in Normal Persons and Patients with Coronary Heart Disease

Ricardo J. Esper¹,

Rogelio A. Machado²,

Roberto A. Nordaby³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1983

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine.

Iliopoulou¹,

Turner²,

Warrington³

1983

Brit J Clinical Pharma

View full text Add to dashboard Cite

1 The acute cardiovascular response to nicardipine was investigated using non invasive techniques in normal subjects. 2 In six subjects, i.v. nicardipine in an increasing dose (0.5-20 mg) was compared with saline, under double-blind conditions. A dose related increase in heart rate and fall in blood pressure were found. Pre-ejection period (PEP) and PEP/left ventricular ejection time (LVET) ratio of the systolic time intervals were shortened in a clearly dose related manner. Total electromechanical systole index (QS2 I) was decreased and LVET index prolonged. 3 In four subjects increasing oral doses (10-40 mg) of nicardipine, administered in a randomized double-blind placebo control design, demonstrated the same pattern, marked changes being found with the 40 mg dose.4 Comparison with nifedipine in a double-blind-placebo controlled balanced trial in six subjects confirmed that 40 mg nicardipine and 20 mg nifedipine exhibited similar effects. Maximum response was reached between 0.5 and 1.5 h, and changes in some cardiovascular variables were still evident at 3 h.

show abstract

Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine.

Iliopoulou¹,

Turner²,

Warrington³

1983

Brit J Clinical Pharma

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Results of a Comparative Study with Adalat: Phonomechano-Cardiograms in Normal Persons and Patients with Coronary Heart Disease

Cited by 1 publication

References 60 publications

Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine.

Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine.

Contact Info

Product

Resources

About